Billaud M - Search Results

1

Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations.

Rossel M, Pasini A, Chappuis S, Geneste O, Fournier L, Schuffenecker I, Takahashi M, van Grunsven LA, Urdiales JL, Rudkin BB, Lenoir GM, Billaud M. Rossel M, et al. Among authors: billaud m. Oncogene. 1997 Jan 23;14(3):265-75. doi: 10.1038/sj.onc.1200831. Oncogene. 1997. PMID: 9018112

2

RET proto-oncogene mutations in French MEN 2A and FMTC families.

Schuffenecker I, Billaud M, Calender A, Chambe B, Ginet N, Calmettes C, Modigliani E, Lenoir GM. Schuffenecker I, et al. Among authors: billaud m. Hum Mol Genet. 1994 Nov;3(11):1939-43. doi: 10.1093/hmg/3.11.1939. Hum Mol Genet. 1994. PMID: 7874109

3

[Neural crest and multiple endocrinopathies].

Pasini A, Michiels FM, Chappuis-Flament S, Geneste O, Rossel M, Fournier L, Feunteun J, Lenoir G, Schuffenecker I, Billaud M. Pasini A, et al. Among authors: billaud m. C R Seances Soc Biol Fil. 1996;190(5-6):557-67. C R Seances Soc Biol Fil. 1996. PMID: 9074721 Review. French.

4

Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.

Michiels FM, Chappuis S, Caillou B, Pasini A, Talbot M, Monier R, Lenoir GM, Feunteun J, Billaud M. Michiels FM, et al. Among authors: billaud m. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3330-5. doi: 10.1073/pnas.94.7.3330. Proc Natl Acad Sci U S A. 1997. PMID: 9096393 Free PMC article.

5

Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domain.

Pasini A, Geneste O, Legrand P, Schlumberger M, Rossel M, Fournier L, Rudkin BB, Schuffenecker I, Lenoir GM, Billaud M. Pasini A, et al. Among authors: billaud m. Oncogene. 1997 Jul 24;15(4):393-402. doi: 10.1038/sj.onc.1201199. Oncogene. 1997. PMID: 9242375

6

Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines.

Chappuis-Flament S, Pasini A, De Vita G, Ségouffin-Cariou C, Fusco A, Attié T, Lenoir GM, Santoro M, Billaud M. Chappuis-Flament S, et al. Among authors: billaud m. Oncogene. 1998 Dec 3;17(22):2851-61. doi: 10.1038/sj.onc.1202202. Oncogene. 1998. PMID: 9879991

7

Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.

Geneste O, Bidaud C, De Vita G, Hofstra RM, Tartare-Deckert S, Buys CH, Lenoir GM, Santoro M, Billaud M. Geneste O, et al. Among authors: billaud m. Hum Mol Genet. 1999 Oct;8(11):1989-99. doi: 10.1093/hmg/8.11.1989. Hum Mol Genet. 1999. PMID: 10484767

8

Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37.

Nony P, Gaude H, Rossel M, Fournier L, Rouault JP, Billaud M. Nony P, et al. Among authors: billaud m. Oncogene. 2003 Dec 11;22(57):9165-75. doi: 10.1038/sj.onc.1207179. Oncogene. 2003. PMID: 14668798

9

Various mechanisms cause RET-mediated signaling defects in Hirschsprung's disease.

Pelet A, Geneste O, Edery P, Pasini A, Chappuis S, Atti T, Munnich A, Lenoir G, Lyonnet S, Billaud M. Pelet A, et al. Among authors: billaud m. J Clin Invest. 1998 Mar 15;101(6):1415-23. doi: 10.1172/JCI375. J Clin Invest. 1998. PMID: 9502784 Free PMC article.

10

Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function?

Takahashi M, Iwashita T, Santoro M, Lyonnet S, Lenoir GM, Billaud M. Takahashi M, et al. Among authors: billaud m. Hum Mutat. 1999;13(4):331-6. doi: 10.1002/(SICI)1098-1004(1999)13:4<331::AID-HUMU11>3.0.CO;2-#. Hum Mutat. 1999. PMID: 10220148

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page